300 related articles for article (PubMed ID: 25628155)
1. Synthesis and antitumor activity evaluation of a novel series of xanthone derivatives.
Guo N; Liu J; Qin L; Jiang D; You X; Lu K; Teng YO; Yu P
J Asian Nat Prod Res; 2015; 17(4):377-83. PubMed ID: 25628155
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
3. Multidimensional optimization of promising antitumor xanthone derivatives.
Azevedo CM; Afonso CM; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Corrêa AG; Reis S; Pinto MM
Bioorg Med Chem; 2013 Jun; 21(11):2941-59. PubMed ID: 23623253
[TBL] [Abstract][Full Text] [Related]
4. Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency.
Wu Y; Hu M; Yang L; Li X; Bian J; Jiang F; Sun H; You Q; Zhang X
Bioorg Med Chem Lett; 2015 Jun; 25(12):2584-8. PubMed ID: 25958244
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, SAR and biological evaluation of natural and non-natural hydroxylated and prenylated xanthones as antitumor agents.
Zhang X; Li X; Ye S; Zhang Y; Tao L; Gao Y; Gong D; Xi M; Meng H; Zhang M; Gao W; Xu X; Guo Q; You Q
Med Chem; 2012 Nov; 8(6):1012-25. PubMed ID: 22779801
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.
Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F
Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells.
Wu J; Dai J; Zhang Y; Wang J; Huang L; Ding H; Li T; Zhang Y; Mao J; Yu S
Drug Des Devel Ther; 2019; 13():4239-4246. PubMed ID: 31853172
[TBL] [Abstract][Full Text] [Related]
8. Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
Castanheiro RA; Pinto MM; Silva AM; Cravo SM; Gales L; Damas AM; Nazareth N; Nascimento MS; Eaton G
Bioorg Med Chem; 2007 Sep; 15(18):6080-8. PubMed ID: 17614292
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study.
Woo S; Jung J; Lee C; Kwon Y; Na Y
Bioorg Med Chem Lett; 2007 Mar; 17(5):1163-6. PubMed ID: 17194586
[TBL] [Abstract][Full Text] [Related]
10. Recent cancer drug development with xanthone structures.
Na Y
J Pharm Pharmacol; 2009 Jun; 61(6):707-12. PubMed ID: 19505360
[TBL] [Abstract][Full Text] [Related]
11. 'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.
Li X; Wu Y; Wang Y; You Q; Zhang X
Molecules; 2017 Oct; 22(11):. PubMed ID: 29077076
[No Abstract] [Full Text] [Related]
12. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro antitumor activities of xanthone derivatives containing 1,4-disubstituted-1,2,3-triazole moiety.
Zou Y; Zhao Q; Hu H; Hu L; Yu S; Xu M; Wu Q
Arch Pharm Res; 2012 Dec; 35(12):2093-104. PubMed ID: 23263803
[TBL] [Abstract][Full Text] [Related]
14. New chiral derivatives of xanthones: synthesis and investigation of enantioselectivity as inhibitors of growth of human tumor cell lines.
Fernandes C; Masawang K; Tiritan ME; Sousa E; de Lima V; Afonso C; Bousbaa H; Sudprasert W; Pedro M; Pinto MM
Bioorg Med Chem; 2014 Feb; 22(3):1049-62. PubMed ID: 24411197
[TBL] [Abstract][Full Text] [Related]
15. [Progress in research of the structural optimization of natural product-like Garcinia caged xanthones].
Wang YY; Zhang XJ; Yang YR; Sun HP; You QD
Yao Xue Xue Bao; 2014 Mar; 49(3):293-302. PubMed ID: 24961098
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Biological Evaluation, and In Silico Studies of Novel Aminated Xanthones as Potential p53-Activating Agents.
Lemos A; Gomes AS; Loureiro JB; Brandão P; Palmeira A; Pinto MMM; Saraiva L; Sousa ME
Molecules; 2019 May; 24(10):. PubMed ID: 31121972
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity and DNA-binding properties of xanthone derivatives.
Shen R; Wang P; Tang N
J Fluoresc; 2010 Nov; 20(6):1287-97. PubMed ID: 20532595
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of a new dimeric xanthone derivative: enhancement of G-quadruplex selectivity and telomere damage.
Franceschin M; Nocioni D; Biroccio A; Micheli E; Cacchione S; Cingolani C; Venditti A; Zizza P; Bianco A; Altieri A
Org Biomol Chem; 2014 Dec; 12(47):9572-82. PubMed ID: 25363232
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity and DNA-binding properties of isoeuxanthone derivatives.
Wang HF; Yan H; Gao X; Niu B; Guo R; Wei L; Xu B; Tang N
Chem Pharm Bull (Tokyo); 2014; 62(3):260-6. PubMed ID: 24583780
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of xanthone derivatives based on α-mangostin and their biological evaluation for anti-cancer agents.
Fei X; Jo M; Lee B; Han SB; Lee K; Jung JK; Seo SY; Kwak YS
Bioorg Med Chem Lett; 2014 May; 24(9):2062-5. PubMed ID: 24717154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
